Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...

Novo sells semaglutide as Ozempic, Rybelsus and Wegovy. The CMS will treat the different forms as a single product in price ...

GetSimpli Oral Tirzepatide is competitively priced, making it an accessible option for those seeking effective weight loss and metabolic health solutions. The regular price is $349.00, but first ...

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Lexaria Bioscience (LEXX) to $7 from $10 and keeps a Buy rating on the ...

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

as the company gets ready to bring its anti-obesity drug tirzepatide, or Mounjaro, to India this year. The company also said it will price its drug competitively for the Indian market. Competitor ...

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

KATIE Price has opened up about her weight loss and insists she’s at her “natural weight” after gaining it on IVF. The star has been bombarded with messages from fans fearing for ...

When the FDA took tirzepatide off of its shortage list in December, the stock price of Hims & Hers fell amid concerns about the telehealth company's GLP-1 business. In January, Citi downgraded its ...